Revolutionary New Laparoscopic Access Device Will Enable SILS(TM) ProceduresPHOENIX, Apr 22, 2009 (BUSINESS WIRE) -- Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare
products, today announced that its Surgical Devices business unit has
launched the Covidien SILS(TM)
Port Multiple Instrument Access Port for laparoscopic surgeries
through a single incision.
The device, now available in the United States and throughout Europe, is
being introduced at the annual convention of the Society of
Gastrointestinal and Endoscopic Surgeons (SAGES), held this week in
Phoenix. SILS(TM) Port is one of several innovative devices featured at
Covidien booth # 511 as part of the Company's Innovation: Delivered
theme at the conference. A Thursday evening educational symposium hosted
by Covidien will feature the SILS(TM) Port and the new Duet TRS(TM) reload
with tissue reinforcement.
The SILS(TM) Port is a single, flexible port that may be fitted through a
small incision in the umbilicus that results in a single "hidden scar,"
a cosmetic advance over the multiple visible scars associated with
standard multi-port laparoscopy. The port has the capacity for up to
three laparoscopic instruments.
"SILS(TM) Port is the first device specifically indicated for multiple
instrument access to the abdomen through a single incision," said Bob
DeSantis, Vice President, Mechanical Devices, Research and Development,
Covidien. "Covidien led the first surgical revolution with multi-port
laparoscopic surgery, and we are now leading the way again with SILS(TM)
procedures," he added.
The SILS(TM) Port is designed to offer surgeons an immediate advancement in
patient care. When the SILS(TM) Port is combined with several other devices
in the Company's portfolio, surgeons will have a complete toolbox
available for this new and emerging technique.
Laparoscopic procedures performed through a single incision are a
significant evolution in the world of surgery. While laparoscopy
traditionally offers better patient outcomes than does the open
approach, including less pain and improved cosmesis, SILS(TM) procedures
have the potential to dramatically extend these benefits.
SILS(TM) is an advanced laparoscopic procedure for which specialty training
is strongly recommended. Contact your local Covidien Surgical Devices
Specialist for training opportunities. For more information about the
product, please visit www.silsport.com.
Suggested link: http://delicious.com/CovidienSurgicalDevices
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien manufactures,
distributes and services a diverse range of industry-leading product
lines in four segments: Medical Devices, Imaging Solutions,
Pharmaceutical Products and Medical Supplies. With 2008 revenue of
nearly $10 billion, Covidien has more than 41,000 employees worldwide in
59 countries, and its products are sold in over 140 countries. Please
to learn more about our business.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5944696&lang=en
Joel Weinberg, 203-492-5576
Manager - Media Relations
Bruce Farmer, 508-452-4372
Coleman Lannum, CFA, 508-452-4343
Brian Nameth, 508-452-4363